Treating rare diseases raise the challenge of minimal previous exposure to similar operations. Defining a learning curve is therefore controversial as many such ‘events’ seem to occur in clusters. Similarly, rare complications might occur in ‘clusters’ hence the response to rare/never events should be interpreted with caution.
